Parresia Launches First Pan-European Survey on AI Use by Healthcare Professionals
Parresia, a media group focused on healthcare professions, has launched the Baromètre ParresIA-GEO365, a pan-European survey examining the use of generative artificial intelligence (AI) among healthcare workers in France, Spain, Germany, and the UK, according to a June 10, 2026, report.
What the Survey Measures
The Baromètre ParresIA-GEO365 investigates five key areas: tools used by professionals, concrete use cases, patient perceptions, sources of trust, and the impact of AI on clinical decisions. It targets 10 healthcare professions, including dentists, orthodontists, pharmacists, and laboratory technicians, as reported by Parresia’s CEO, Mathieu Besson.
“Generative AI is no longer a future prospect—it is already present in clinics, pharmacies, and laboratories,” Besson stated. “This survey will document its integration with rigor.”
Why It Matters
The initiative aligns with Parresia’s broader strategy to develop a Generative Engine Optimisation (GEO) platform, which aims to enhance the visibility of health brands in AI-generated content, such as responses from ChatGPT, Gemini, and Claude. By mapping real-world AI practices, Parresia plans to provide data-driven insights for pharmaceutical and medical device companies, according to the report.
This effort reflects a growing industry focus on AI in healthcare. A 2025 study by the European Commission found that 72% of clinicians in member states use AI tools for diagnostics or administrative tasks, though usage varies widely by country and specialty.
Survey Timeline and Participation
The Baromètre ParresIA-GEO365 is open for responses until June 28, 2026. Participants include professionals from the four countries, with results expected to highlight regional differences in AI adoption. Parresia has not disclosed the exact number of respondents or methodology details, but the survey is described as “the first comprehensive analysis of AI usage in European healthcare,” per the report.
Healthcare AI adoption has accelerated since 2023, driven by tools like AI-powered imaging systems and virtual assistants. However, concerns about data privacy, algorithmic bias, and clinical validation persist, according to a 2024 report by the World Health Organization.
What’s Next for AI in Healthcare?
The survey’s findings could influence regulatory frameworks and industry standards. In 2026, the EU finalized its AI Act, which classifies healthcare AI as “high-risk” and mandates strict transparency requirements. Parresia’s data may help stakeholders navigate these rules, as noted in the report.
“Understanding how AI is used today is critical for shaping its future,” said Dr. Elena Martínez, a Spanish medical ethicist not affiliated with Parresia. “Surveys like this provide a foundation for responsible innovation.”